Cell Biology and Metabolism
The N-terminal Moiety of CDC25Mm, a GDP/GTP Exchange Factor of Ras Proteins, Controls the Activity of the Catalytic Domain: MODULATION BY CALMODULIN AND CALPAIN*

https://doi.org/10.1074/jbc.272.10.6671Get rights and content
Under a Creative Commons license
open access

This work describes the in vitro properties of full-length CDC25Mm (1262 amino acid residues), a GDP/GTP exchange factor (GEF) of H-ras p21. CDC25Mm, isolated as a recombinant protein in Escherichia coli and purified by various chromatographic methods, could stimulate the H-ras p21·GDP dissociation rate; however, its specific activity was 25 times lower than that of the isolated catalytic domain comprising the last C-terminal 285 residues (C-CDC25Mm285) and 5 times lower than the activity of the C-terminal half-molecule (631 residues). This reveals a negative regulation of the catalytic domain by other domains of the molecule. Accordingly, the GEF activity of CDC25Mm was increased severalfold by the Ca2+-dependent protease calpain that cleaves around a PEST-like region (residues 798-853), producing C-terminal fragments of 43-56 kDa. In agreement with the presence of an IQ motif on CDC25Mm (residues 202-229), calmodulin interacted functionally with the exchange factor. Depending on the calmodulin concentration an inhibition up to 50% of the CDC25Mm-induced nucleotide exchange activity on H-ras p21 was observed, an effect requiring Ca2+ ions. Calmodulin also inhibited C-CDC25Mm285 but with a ∼100 times higher IC50 than in the case of CDC25Mm (∼10 μM versus 0.1 μM, respectively). Together, these results emphasize the role of the other domains of CDC25Mm in controlling the activity of the catalytic domain and support the involvement of calmodulin and calpain in the in vivo regulation of the CDC25Mm activity.

Cited by (0)

*

This work was supported by the European Community (contract: BIOTECH BIO2-CT93-00005), Ligue Nationale Fran¸aise Contre le Cancer, Association pour la Recherche sur le Cancer (Grant 6377), Fédération Nationale des Centres de Lutte Contre le Cancer and Groupement de Recherches et d'Etudes sur les Génomes. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a fellowship of the Association pour la Recherche sur le Cancer.